Conway Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $872K | Hold |
11,145
| – | – | 0.39% | 27 |
|
|
2025
Q1 | $808K | Sell |
11,145
-30
| -0.3% | -$2.17K | 0.4% | 27 |
|
|
2024
Q4 | $827K | Hold |
11,175
| – | – | 0.37% | 28 |
|
|
2024
Q3 | $737K | Sell |
11,175
-4,450
| -28% | -$294K | 0.36% | 30 |
|
|
2024
Q2 | $1.44M | Hold |
15,625
| – | – | 0.73% | 22 |
|
|
2024
Q1 | $1.49M | Sell |
15,625
-600
| -4% | -$57.3K | 0.84% | 21 |
|
|
2023
Q4 | $1.24M | Sell |
16,225
-675
| -4% | -$51.5K | 0.8% | 20 |
|
|
2023
Q3 | $1.17M | Sell |
16,900
-4,250
| -20% | -$294K | 0.86% | 22 |
|
|
2023
Q2 | $2M | Sell |
21,150
-2,425
| -10% | -$229K | 1.4% | 15 |
|
|
2023
Q1 | $1.95M | Sell |
23,575
-900
| -4% | -$74.5K | 1.6% | 15 |
|
|
2022
Q4 | $1.83M | Sell |
24,475
-2,600
| -10% | -$194K | 1.85% | 15 |
|
|
2022
Q3 | $2.24M | Sell |
27,075
-350
| -1% | -$28.9K | 2% | 14 |
|
|
2022
Q2 | $2.61M | Sell |
27,425
-425
| -2% | -$40.4K | 2.33% | 12 |
|
|
2022
Q1 | $3.28M | Buy |
27,850
+2,650
| +11% | +$312K | 2.1% | 13 |
|
|
2021
Q4 | $3.26M | Buy |
25,200
+2,500
| +11% | +$324K | 1.92% | 14 |
|
|
2021
Q3 | $2.57M | Sell |
22,700
-275
| -1% | -$31.1K | 1.74% | 15 |
|
|
2021
Q2 | $2.38M | Buy |
22,975
+925
| +4% | +$95.8K | 1.63% | 15 |
|
|
2021
Q1 | $1.84M | Sell |
22,050
-200
| -0.9% | -$16.7K | 1.38% | 15 |
|
|
2020
Q4 | $2.03M | Buy |
+22,250
| New | +$2.03M | 1.49% | 13 |
|